Year Founded: 1931
Number of Employees: 45, 100
Approx. Annual Revenues: $10.7 billion net sales
Baxter’s BioPharma Solutions business collaborates with
pharmaceutical companies to support commercialization objectives
for their molecules. As a parenterals specialist with over 80 years
of expertise, BioPharma Solutions offers contract manufacturing
form/fill/finish services and solutions for injectables designed to
meet complex and traditional sterile manufacturing challenges. As
a global injectables specialist, we can help solve unique challenges
with confidence of delivery, service and integrity.
Baxter’s expansive network offers more than 50 manufacturing
facilities across six continents and our global presence provides
opportunities for unique sterile contract manufacturing
collaborations. The power of an extensive global network lies in
the coordination of, and efficiencies resulting from, a systemic
approach to cGMP manufacturing. Baxter has manufacturing
sites across the globe in support of a diverse portfolio of delivery
systems and manufacturing solutions.
Our Parenteral Delivery Systems include: prefilled syringes,
liquid/lyophilized vials, cartridges, frozen premix systems, liquid
premix systems, BIO-SET luer system, diluents for reconstitution,
ampoules, powder-filled vials, and sterile crystallization.
Our Drug Categories include: small molecules, biologics,
vaccines, cytotoxics, highly potent compounds, ADCs (antibody-
drug conjugates), and cephalosporins/pencillins.
Our award-winning state-of-the-art facilities specialize in sterile
contract manufacturing services and have primary locations in:
Bloomington, Indiana USA – The Bloomington facility is a leader
in sterile contracting manufacturing and offers form/fill/finish
services and solutions for injectables designed to meet complex
and traditional sterile manufacturing challenges.
Halle/Westfalen, Germany – Recognized as a world-class
manufacturer of highly potent and cytotoxic drugs, the Halle/
Westfalen facility offers dedicated clinical through commercialization
production with integrated services and technologies. To support
the growing needs of cytotoxic manufacturing, the Halle/Westfalen
facility completed an 1,800 square meter capacity expansion. This
additional capacity further expands their leadership position as one
of the largest capacity CMOs for lyophilized cytotoxic parenterals.
Round Lake, Illinois USA – Baxter is the world’s leading provider
of manufacturer-prepared IV solutions and our Round Lake
facility is a best-in-class aseptic solution manufacturer. Baxter’s
portfolio of premixed drugs is the broadest in the industry and we
are the only CMO to offer a manufacturer-prepared, commercial-scale aseptic filling process for premixed drugs in flexible IV bags.
Baxter BioPharma Solutions